INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Operating income 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) annual operating income history from SEC filings — each fiscal year as reported.
-$493.4MFY2025 · since FY2016: $115.3M → -$493.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$493.4M | -1836.5% |
| FY2024 | $28.4M | -74.5% |
| FY2023 | $111.5M | -53.3% |
| FY2022 | $238.9M | +21.1% |
| FY2021 | $197.2M | +30.3% |
| FY2020 | $151.4M | +61.4% |
| FY2019 | $93.8M | -15.5% |
| FY2018 | $111.0M | +147.7% |
| FY2017 | $44.8M | -61.2% |
| FY2016 | $115.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IART financial trends
IART RevenueIART Net incomeIART Net marginIART Gross profitIART Gross marginIART Operating marginIART Operating cash flowIART Free cash flowIART Capital expendituresIART Return on equityIART Stock buybacksIART Dividends paidIART Total assetsIART Total liabilitiesIART Shareholders’ equityIART overview →